Viewing Study NCT01443702


Ignite Creation Date: 2025-12-25 @ 4:01 AM
Ignite Modification Date: 2025-12-26 @ 2:54 AM
Study NCT ID: NCT01443702
Status: COMPLETED
Last Update Posted: 2013-12-02
First Post: 2011-09-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Use of Lapis Judaicus to Dissolve Kidney Stones
Sponsor: Shiraz University of Medical Sciences
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2013-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators will investigate the safety and effectiveness of an Iranian traditional medicine regarding its ability to dissolve existing kidney stones. Calcium stone formers will be recruited for a 12 week trial. Each subject will receive Lapis judaicus or placebo in random order. End points are changes in urinary chemistries and stone burden by Ultra sonography / CT scan.

It will be used in proven calcium stone forming adults who are not pregnant. This phase is a double blind, randomized, placebo controlled Entry, first and 12 week 24 hour urine supersaturations, pH and sodium determinations will be collected. Entry and final stone quantification Ultra sonography / CT scan will be performed. End points will be changes in urine chemistry/supersaturation and stone quantitative stone volume.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: